MIR518f: A Non-Coding RNA Molecule as A Drug Target and Biomarker

Target Name: MIR518F

NCBI ID: G574472

MIR518F

MIR518f: A Non-Coding RNA Molecule as A Drug Target and Biomarker

MicroRNA 518f (MIR518f) is a non-coding RNA molecule that plays a critical role in various biological processes. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer. In this article, we will discuss the research on MIR518f as a drug target and its potential as a biomarker.

MIR518f is a part of the microRNA (miRNA) family, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation. These RNAs act by binding to specific target genes and promoting their translation into proteins. MIR518f is a highly conserved miRNA, with a length of 29 amino acids and a predicted localization to the endoplasmic reticulum (ER).

MIR518f has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and cell-cell signaling. It has been shown to regulate the expression of target genes that are involved in cell cycle progression, apoptosis, and angiogenesis.

One of the most promising aspects of MIR518f is its potential as a drug target. The high conservation sequence of MIR518f makes it an attractive target for small molecule inhibitors. Several studies have shown that MIR518f can be inhibited by small molecules, including inhibitors of the translation machinery and inhibitors of the miRNA pathway. These inhibitors have been shown to reduce the levels of MIR518f in cells and to induce apoptosis in cancer cells.

In addition to its potential as a drug target, MIR518f has also been shown to be a potential biomarker for several diseases, including cancer. The miRNA pathway is a well-established biomarker for cancer, as it is often dysregulated in cancer cells. The levels of MIR518f in cancer cells are often increased compared to normal cells, and inhibition of MIR518f has been shown to be effective in inhibiting the growth and survival of cancer cells.

MIR518f has also been shown to be involved in the regulation of cellular processes that are important for human health, such as cell proliferation, apoptosis, and inflammation. It has been shown to regulate the expression of genes involved in cell cycle progression, apoptosis, and inflammation, and these processes are often disrupted in diseases such as cancer and neurodegenerative diseases.

In conclusion, MIR518f is a promising drug target and biomarker for several diseases. Its high conservation sequence and its role in cell proliferation and apoptosis make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the mechanisms of MIR518f as a drug target and its potential as a biomarker.

Protein Name: MicroRNA 518f

The "MIR518F Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR518F comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets